DALLAS, Feb. 19, 2014 /PRNewswire/ -- Securities lawyers at Deans & Lyons announce an investigation of the board of Forest Laboratories, Inc. (NYSE: FRX) in connection the Actavis plc buyout for $26.04 and 0.3306 shares of Actavis. Concerned FRX investors are encouraged to contact attorney Hamilton Lindley by clicking here.

"The potential investigation concerns whether the proposed deal properly values Forest's common stock," said securities lawyer Hamilton Lindley. "Our potential shareholder lawsuit will seek to ensure that all relevant information is disclosed and that the Forest Laboratories, Inc. shareholders receive the highest price reasonably available for their stock." 

Deans & Lyons has significant experience representing shareholders in securities lawsuits nationwide. FRX stockholders – or anyone with knowledge about this situation – should contact lawyer Hamilton Lindley at hlindley@deanslyons.com or 877-819-8033 with questions or concerns.

Hamilton Lindley
DEANS & LYONS LLP
325 North Saint Paul Street, Suite 1500
Dallas, TX 75201
Phone: 214-736-7861
Fax: 214-965-8505
Toll-free: 877-819-8033
hlindley@deanslyons.com

www.deanslyons.com   

SOURCE Deans & Lyons LLP

Copyright 2014 PR Newswire

Forest Road Acquisition (NYSE:FRX)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Forest Road Acquisition Charts.
Forest Road Acquisition (NYSE:FRX)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Forest Road Acquisition Charts.